Advanced simulations of biomolecular systems using a supercomputer
Breakthrough Molecular Dynamics Research via an Anton 3 Supercomputer
['FUNDING_OTHER'] · CARNEGIE-MELLON UNIVERSITY · NIH-11159637
This study is all about using a super-fast computer to help scientists better understand how our bodies work at the molecular level, which could lead to new breakthroughs in medicine for everyone.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | CARNEGIE-MELLON UNIVERSITY (nih funded) |
| Locations | 1 site (PITTSBURGH, UNITED STATES) |
| Trial ID | NIH-11159637 on ClinicalTrials.gov |
What this research studies
This research provides access to the Anton 3 supercomputer, which allows scientists to simulate complex biomolecular systems at unprecedented speeds. By enabling simulations that can model biological processes over longer timescales and larger molecular systems, this project aims to enhance our understanding of critical biological functions. The research will facilitate collaboration among the biomedical community to tackle significant biological questions that could lead to new insights and innovations in medicine.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals with conditions that involve complex biomolecular interactions, such as genetic disorders or certain cancers.
Not a fit: Patients with conditions that do not involve significant biomolecular processes or those who are not engaged in research collaborations may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to breakthroughs in understanding diseases and developing new treatments by simulating molecular interactions more effectively.
How similar studies have performed: Previous research utilizing earlier versions of the Anton supercomputer has shown significant success in advancing our understanding of biomolecular dynamics, indicating a strong potential for continued breakthroughs with the Anton 3.
Where this research is happening
PITTSBURGH, UNITED STATES
- CARNEGIE-MELLON UNIVERSITY — PITTSBURGH, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: BLOOD, PHILIP D. — CARNEGIE-MELLON UNIVERSITY
- Study coordinator: BLOOD, PHILIP D.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.